A detailed history of Amundi transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Amundi holds 654,571 shares of TEVA stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
654,571
Previous 540,471 21.11%
Holding current value
$11.5 Million
Previous $7.63 Million 39.47%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $1.46 Million - $1.99 Million
114,100 Added 21.11%
654,571 $10.6 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $1.13 Million - $1.52 Million
105,578 Added 24.28%
540,471 $7.63 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $655,365 - $857,947
-80,710 Reduced 15.65%
434,893 $4.54 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $46,974 - $67,196
6,280 Added 1.23%
515,603 $5.26 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $420,696 - $553,332
58,430 Added 12.96%
509,323 $3.84 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $338,972 - $461,019
40,547 Added 9.88%
450,893 $3.99 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $139,522 - $166,374
17,550 Added 4.47%
410,346 $3.74 Million
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $578,174 - $1.01 Million
84,282 Added 27.32%
392,796 $3.47 Million
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $8,066 - $11,367
1,093 Added 0.36%
308,514 $2.13 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $386,510 - $495,134
52,730 Added 20.7%
307,421 $3.13 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $44,745 - $57,716
5,664 Added 2.27%
254,691 $2.34 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $76,718 - $93,197
-9,155 Reduced 3.55%
249,027 $2.43 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $2.56 Million - $2.98 Million
258,182 New
258,182 $2.56 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.